XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.24.3

License Agreements (Details) $ in Millions |  | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Mar. 22, 2022 USD ($) payment | Dec. 31, 2023 USD ($) | Sep. 30, 2024 USD ($) | Dec. 31, 2023 USD ($)
Lonza milestone payment |  |  |  |
License Agreements |  |  |  |
Amount of license costs payable |  |  | $ 0.0 |
Lonza milestone payment | Research and development |  |  |  |
License Agreements |  |  |  |
License fee |  | $ 0.4 | 0.4 |
Wuxi Biologics License |  |  |  |
License Agreements |  |  |  |
Amount of license costs payable |  |  | $ 0.0 |
Agreement with Pfizer |  |  |  |
License Agreements |  |  |  |
Number of development and regulatory milestone payments | payment | 11 |  |  |
Maximum amount of development and regulatory milestone payments | $ 70.0 |  |  |
Maximum amount of sales milestone payments | $ 525.0 |  |  |
Maximum annual earned royalty at a marginal royalty rate | 20.00% |  |  |
Development Of research and development |  |  |  | $ 1.0

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of license costs payable. + References No definition available. + Details
Name: | zura_AccruedLicenseCosts
Namespace Prefix: | zura_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of development milestone recognized as a component of research and development. + References No definition available. + Details
Name: | zura_AmountOfDevelopmentMilestoneRecognizedAsComponentOfResearchAndDevelopment
Namespace Prefix: | zura_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the maximum amount of development and regulatory milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. + References No definition available. + Details
Name: | zura_AssetAcquisitionConsiderationMaximumDevelopmentAndRegulatoryMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix: | zura_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the maximum percentage of payment of annual earned royalty at a marginal royalty rate. + References No definition available. + Details
Name: | zura_AssetAcquisitionConsiderationMaximumPercentageOfPaymentOfAnnualEarnedRoyaltyAtMarginalRoyaltyRate
Namespace Prefix: | zura_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the maximum amount of sales milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. + References No definition available. + Details
Name: | zura_AssetAcquisitionConsiderationMaximumSalesMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix: | zura_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the number of development and regulatory milestone payments in asset acquisition. + References No definition available. + Details
Name: | zura_AssetAcquisitionConsiderationNumberOfDevelopmentAndRegulatoryMilestonePayments
Namespace Prefix: | zura_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount represents of license expense. + References No definition available. + Details
Name: | zura_LicenseExpense
Namespace Prefix: | zura_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=zura_LonzaLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=zura_WuxiBiologicsLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=zura_LicenseAgreementAndSeriesA1SubscriptionAndShareholdersAgreementWithPfizerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |